Variant report

Variant	nsv898779
Chromosome Location	chr12:11134701-11174276
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:134)
CpG islands
(count:611)
Chromatin interactive
region (count:10)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:134 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr12:11168444-11168649	HepG2	liver:	n/a	n/a
2	BATF	chr12:11134866-11135249	GM12878	blood:	n/a	n/a
3	BATF	chr12:11134883-11135228	GM12878	blood:	n/a	n/a
4	BHLHE40	chr12:11168360-11168714	HepG2	liver:	n/a	n/a
5	BHLHE40	chr12:11134926-11135203	GM12878	blood:	n/a	n/a
6	BRCA1	chr12:11168480-11168660	HepG2	liver:	n/a	n/a
7	CEBPB	chr12:11135657-11135714	HepG2	liver:	n/a	n/a
8	CEBPB	chr12:11148042-11148079	K562	blood:	n/a	n/a
9	CEBPB	chr12:11170024-11170162	HepG2	liver:	n/a	chr12:11170139-11170150
10	CEBPB	chr12:11167458-11167736	HepG2	liver:	n/a	chr12:11167582-11167593
11	CTCF	chr12:11147020-11147170	GM12869	blood:	n/a	n/a
12	CTCF	chr12:11169160-11169310	HepG2	liver:	n/a	n/a
13	CTCF	chr12:11168980-11169130	HAc	cerebellar:	n/a	n/a
14	CTCF	chr12:11169160-11169310	Caco-2	colon:	n/a	n/a
15	CTCF	chr12:11169080-11169230	RPTEC	kidney:	n/a	n/a
16	CTCF	chr12:11169160-11169310	HEK293	kidney:	n/a	n/a
17	CTCF	chr12:11143647-11143668	GM13977	blood:	n/a	n/a
18	E2F4	chr12:11152173-11152390	MCF10A-Er-Src	breast:	n/a	n/a
19	E2F4	chr12:11173618-11173950	MCF10A-Er-Src	breast:	n/a	n/a
20	E2F4	chr12:11155484-11155547	MCF10A-Er-Src	breast:	n/a	n/a
21	EBF1	chr12:11170634-11170935	GM12878	blood:	n/a	chr12:11170793-11170802 chr12:11170793-11170803 chr12:11170791-11170804
22	ELF1	chr12:11168373-11168750	HepG2	liver:	n/a	n/a
23	EP300	chr12:11134832-11135375	SK-N-SH_RA	brain:	n/a	n/a
24	EP300	chr12:11168276-11168877	HepG2	liver:	n/a	n/a
25	EP300	chr12:11169625-11169923	SK-N-SH_RA	brain:	n/a	n/a
26	EP300	chr12:11134868-11135329	SK-N-SH_RA	brain:	n/a	n/a
27	EP300	chr12:11168480-11168651	HepG2	liver:	n/a	n/a
28	EP300	chr12:11134989-11135222	GM12878	blood:	n/a	n/a
29	EP300	chr12:11168317-11168866	HepG2	liver:	n/a	n/a
30	EP300	chr12:11167186-11167211	K562	blood:	n/a	n/a
31	FOXA1	chr12:11168275-11168843	HepG2	liver:	n/a	n/a
32	FOXA1	chr12:11168229-11168882	HepG2	liver:	n/a	n/a
33	FOXA1	chr12:11168230-11168849	HepG2	liver:	n/a	n/a
34	FOXA1	chr12:11168099-11168858	HepG2	liver:	n/a	n/a
35	FOXA2	chr12:11168394-11168826	HepG2	liver:	n/a	n/a
36	GATA2	chr12:11168114-11168760	HUVEC	blood vessel:	n/a	n/a
37	GATA3	chr12:11143062-11143262	SH-SY5Y	brain:	n/a	n/a
38	HDAC2	chr12:11168257-11168879	HepG2	liver:	n/a	n/a
39	HDAC2	chr12:11168351-11168795	HepG2	liver:	n/a	n/a
40	HEY1	chr12:11168466-11168892	HepG2	liver:	n/a	n/a
41	HNF4A	chr12:11168259-11168819	HepG2	liver:	n/a	chr12:11168634-11168649
42	HNF4A	chr12:11168343-11168835	HepG2	liver:	n/a	chr12:11168634-11168649
43	HNF4G	chr12:11168316-11168857	HepG2	liver:	n/a	n/a
44	HNF4G	chr12:11168264-11168911	HepG2	liver:	n/a	n/a
45	JUND	chr12:11166774-11167165	HepG2	liver:	n/a	chr12:11166993-11167004
46	MAFF	chr12:11139035-11139264	HepG2	liver:	n/a	chr12:11139143-11139161
47	MAFK	chr12:11162847-11162877	HepG2	liver:	n/a	n/a
48	MAFK	chr12:11138998-11139296	HepG2	liver:	n/a	chr12:11139145-11139160
49	MAFK	chr12:11139097-11139188	Hela-S3	cervix:	n/a	chr12:11139145-11139160
50	MAFK	chr12:11168515-11168781	HepG2	liver:	n/a	n/a

(count:611 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:11140560-11140610	HCPEpiC	choroid plexus:	n/a
2	chr12:11140560-11140610	HCPEpiC	choroid plexus:	n/a
3	chr12:11139710-11139760	CMK	blood:	n/a
4	chr12:11151622-11151672	HCT-116	colon:	n/a
5	chr12:11149362-11149412	PFSK-1	brain:	n/a
6	chr12:11151622-11151672	HCPEpiC	choroid plexus:	n/a
7	chr12:11151478-11151528	BJ	skin:	n/a
8	chr12:11149362-11149412	PrEC	prostate:	n/a
9	chr12:11139304-11139354	SK-N-MC	brain:	n/a
10	chr12:11139962-11140012	GM19239	blood:	n/a
11	chr12:11151224-11151274	HUVEC	blood vessel:	n/a
12	chr12:11139710-11139760	HRE	kidney:	n/a
13	chr12:11139304-11139354	GM12892	blood:	n/a
14	chr12:11151522-11151572	SK-N-SH	brain:	n/a
15	chr12:11140560-11140610	GM06990	blood:	n/a
16	chr12:11139304-11139354	A549	lung:	n/a
17	chr12:11139304-11139354	AG10803	skin:	n/a
18	chr12:11151522-11151572	AG09309	skin:	n/a
19	chr12:11139962-11140012	Hela-S3	cervix:	n/a
20	chr12:11151622-11151672	U87	brain:	n/a
21	chr12:11140560-11140610	AoSMC	blood vessel:	n/a
22	chr12:11151478-11151528	NT2-D1	testis:	n/a
23	chr12:11151224-11151274	GM19239	blood:	n/a
24	chr12:11149362-11149412	Hela-S3	cervix:	n/a
25	chr12:11139710-11139760	MCF10A-Er-Src	breast:	n/a
26	chr12:11140560-11140610	HCM	heart:	n/a
27	chr12:11151478-11151528	HIPEpiC	eye:	n/a
28	chr12:11139710-11139760	AG04450	lung:	fetal
29	chr12:11151622-11151672	HRCEpiC	kidney:	n/a
30	chr12:11151622-11151672	ProgFib	skin:	n/a
31	chr12:11149362-11149412	GM12878	blood:	n/a
32	chr12:11151622-11151672	AG04450	lung:	fetal
33	chr12:11139304-11139354	AG09319	gingival:	n/a
34	chr12:11139304-11139354	PFSK-1	brain:	n/a
35	chr12:11151430-11151480	HCM	heart:	n/a
36	chr12:11139962-11140012	NHDF-neo	bronchial:	n/a
37	chr12:11151522-11151572	GM12878	blood:	n/a
38	chr12:11151522-11151572	Hela-S3	cervix:	n/a
39	chr12:11149362-11149412	HCF	heart:	n/a
40	chr12:11151430-11151480	GM19239	blood:	n/a
41	chr12:11139304-11139354	BE2_C	brain:	n/a
42	chr12:11139962-11140012	HNPCEpiC	eye:	n/a
43	chr12:11151224-11151274	ECC-1	luminal epithelium:	n/a
44	chr12:11151224-11151274	NT2-D1	testis:	n/a
45	chr12:11140560-11140610	Caco-2	colon:	n/a
46	chr12:11151622-11151672	NHDF-neo	bronchial:	n/a
47	chr12:11139710-11139760	GM12892	blood:	n/a
48	chr12:11139304-11139354	T-47D	breast:	n/a
49	chr12:11151522-11151572	SKMC	muscle:	n/a
50	chr12:11151622-11151672	A549	lung:	n/a

(count:10 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:11153714..11156559-chr12:11162296..11164278,2	MCF-7	breast:
2	chr12:11158423..11160257-chr12:11164352..11165951,2	MCF-7	breast:
3	chr12:11169301..11171201-chr12:11322573..11325255,2	MCF-7	breast:
4	chr12:11157746..11159406-chr12:11165545..11167423,2	K562	blood:
5	chr12:11154648..11156385-chr12:11157901..11159498,2	K562	blood:
6	chr12:11158423..11160257-chr12:11164352..11165951,2	MCF-7	breast:
7	chr12:11009323..11011109-chr12:11168207..11170860,2	K562	blood:
8	chr12:11153714..11156559-chr12:11162296..11164278,2	MCF-7	breast:
9	chr12:11157746..11159406-chr12:11165545..11167423,2	K562	blood:
10	chr12:11154648..11156385-chr12:11157901..11159498,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PRH1-1	chr12:11158533-11158868	NONHSAT026915

No data

Variant related genes	Relation type
TAS2R20	TF binding region
TAS2R50	TF binding region
TAS2R20	CpG island
TAS2R50	CpG island
ENSG00000111215	chromatin interactions
ENSG00000256537	chromatin interactions
ENSG00000212127	chromatin interactions
ENSG00000256712	chromatin interactions

Extended variants
information (count: 1737 )
Associated
traits (count: 103 )

Variant overlapped rSNPs/rCNVs (count:1737 , 50 per page) page: 1 2 3 4 5 6 7 ... 35

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2900554	chr12:11134701-11134702	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs141053822	chr12:11134906-11134907	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs553477576	chr12:11134910-11134911	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs190220923	chr12:11134920-11134921	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs531725343	chr12:11134923-11134924	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs551313644	chr12:11134938-11134939	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs571315424	chr12:11134973-11134974	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs116290704	chr12:11135067-11135068	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs547310445	chr12:11135069-11135070	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs115245620	chr12:11135149-11135150	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs536091992	chr12:11135166-11135167	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs183356998	chr12:11135211-11135212	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs576103932	chr12:11135221-11135222	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs538743019	chr12:11135229-11135230	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs187848042	chr12:11135232-11135233	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs201182127	chr12:11135270-11135271	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs113978113	chr12:11135285-11135286	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs540902362	chr12:11135359-11135360	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs191039600	chr12:11135399-11135400	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs574165495	chr12:11135404-11135405	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs537696282	chr12:11135415-11135416	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs199737671	chr12:11135445-11135446	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs542810159	chr12:11135457-11135458	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs563096053	chr12:11135458-11135459	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs4763603	chr12:11135476-11135477	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
26	rs551446762	chr12:11135576-11135577	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs182560318	chr12:11135611-11135612	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs527652218	chr12:11135630-11135631	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs78400021	chr12:11135654-11135655	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs567407373	chr12:11135700-11135701	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs74589771	chr12:11135721-11135722	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs543352413	chr12:11135726-11135727	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs552661878	chr12:11135729-11135730	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs566492827	chr12:11135771-11135772	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs569822610	chr12:11135781-11135782	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs563251655	chr12:11135815-11135816	Weak transcription Enhancers Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs147882003	chr12:11135842-11135843	Weak transcription Enhancers Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs558661130	chr12:11135922-11135923	Weak transcription Enhancers Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs572090554	chr12:11135934-11135935	Weak transcription Enhancers Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs367987842	chr12:11135976-11135977	Weak transcription Enhancers Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs74062413	chr12:11136010-11136011	Weak transcription Enhancers Strong transcription Bivalent Enhancer ZNF genes & repeats	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs140472738	chr12:11136020-11136021	Weak transcription Enhancers Strong transcription Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
43	rs374119025	chr12:11136050-11136051	Weak transcription Enhancers Strong transcription Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
44	rs574302026	chr12:11136113-11136114	Weak transcription Enhancers Strong transcription Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
45	rs543299516	chr12:11136117-11136118	Weak transcription Enhancers Strong transcription Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
46	rs573253483	chr12:11136178-11136179	Weak transcription Enhancers Strong transcription Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
47	rs150432174	chr12:11136191-11136192	Weak transcription Enhancers Strong transcription Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
48	rs545121737	chr12:11136210-11136211	Weak transcription Enhancers Strong transcription Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
49	rs188049485	chr12:11136212-11136213	Weak transcription Enhancers Strong transcription Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
50	rs4430593	chr12:11136251-11136252	Weak transcription Enhancers Strong transcription Bivalent Enhancer ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:103)

Disease	PMID	Source
Acute lymphoblastic leukemia	17690704	CNVD
Medulloblastoma	16968546	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Hepatocellular carcinoma	16750200	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Breast cancer	22032731	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Prostate cancer	21965145	CNVD
Acute myeloid leukemia	16864856	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Disorders of sex development	21048976	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Prostate cancer	19156837	CNVD
Emphysema	19352772	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Malignant germ cell tumour	17285132	CNVD
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Ewing''s sarcoma	17952124	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21858162	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21785460	CNVD
Myelodysplastic syndrome	21251322	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21509527	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21611746	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Myelofibrosis	22110671	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Squamous cell cancer	19607727	CNVD
Prostate cancer	16573809	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Glioblastoma multiforme	22286061	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Acute myeloid leukemia	17268525	CNVD
Acute monocytic leukemia	16498392	CNVD
Prostate cancer	16461572	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Breast cancer	17133270	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Ependymoma	18628472	CNVD
Leukemia	18628472	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Ovarian cancer	21720365	CNVD
Melanoma	20877625	CNVD
Ovarian cancer	21781307	CNVD
Acute myeloid leukemia	17237825	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Breast cancer	22522925	CNVD
Acute myeloid leukemia	20729466	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Bipolar disorder	19114987	CNVD
early-passage human iPS cells	21368824	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Incontinentia Pigmenti	22033527	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Pancreatic cancer	17952125	CNVD
Glioma	20126413	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:493 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:11095200-11148800	Weak transcription	HepG2	liver
2	chr12:11102000-11135600	Weak transcription	Aorta	Aorta
3	chr12:11111800-11142800	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
4	chr12:11114000-11149200	Weak transcription	GM12878-XiMat	blood
5	chr12:11114400-11180200	Weak transcription	Primary B cells from peripheral blood	blood
6	chr12:11114600-11135400	Weak transcription	Dnd41	blood
7	chr12:11114600-11142800	Weak transcription	Primary hematopoietic stem cells short term culture	blood
8	chr12:11114600-11146400	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
9	chr12:11114600-11146800	Weak transcription	Ovary	ovary
10	chr12:11121800-11142800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
11	chr12:11122000-11136800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
12	chr12:11122000-11142600	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
13	chr12:11122000-11146200	Weak transcription	Left Ventricle	heart
14	chr12:11122000-11170200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
15	chr12:11122200-11168000	Weak transcription	HUVEC	blood vessel
16	chr12:11126400-11142800	Weak transcription	Primary B cells from cord blood	blood
17	chr12:11126400-11143000	Weak transcription	HSMM	muscle
18	chr12:11128200-11142800	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
19	chr12:11129200-11167600	Weak transcription	Rectal Mucosa Donor 31	rectum
20	chr12:11129400-11136000	Weak transcription	Lung	lung
21	chr12:11132000-11154800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
22	chr12:11132400-11146200	Weak transcription	Adipose Nuclei	Adipose
23	chr12:11133400-11136200	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
24	chr12:11133800-11135000	Weak transcription	Brain Hippocampus Middle	brain
25	chr12:11133800-11136600	Enhancers	Primary T helper naive cells fromperipheralblood	blood
26	chr12:11133800-11142600	Weak transcription	Brain Substantia Nigra	brain
27	chr12:11134000-11142800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
28	chr12:11134200-11135400	Enhancers	Primary T helper naive cells from peripheral blood	blood
29	chr12:11134200-11136400	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
30	chr12:11134200-11136600	Enhancers	Primary T helper cells fromperipheralblood	blood
31	chr12:11134200-11136600	Enhancers	Primary T regulatory cells fromperipheralblood	blood
32	chr12:11134200-11136600	Enhancers	Primary T killer memory cells from peripheral blood	blood
33	chr12:11134200-11136800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
34	chr12:11134400-11135000	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
35	chr12:11134400-11135800	Weak transcription	Primary hematopoietic stem cells	blood
36	chr12:11134400-11136000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
37	chr12:11134400-11136400	Enhancers	Primary T cells fromperipheralblood	blood
38	chr12:11134400-11136600	Enhancers	Primary T helper cells PMA-I stimulated	--
39	chr12:11134600-11134800	Enhancers	NHDF-Ad	bronchial
40	chr12:11134600-11135000	Flanking Active TSS	Primary T cells from cord blood	blood
41	chr12:11134600-11135000	Flanking Active TSS	Primary T helper memory cells from peripheral blood 1	blood
42	chr12:11134600-11135000	Enhancers	Fetal Thymus	thymus
43	chr12:11134800-11135200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
44	chr12:11134800-11135800	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
45	chr12:11134800-11166800	Weak transcription	NHDF-Ad	bronchial
46	chr12:11135000-11135400	Enhancers	Primary T cells from cord blood	blood
47	chr12:11135000-11135400	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
48	chr12:11135000-11135800	Enhancers	Brain Hippocampus Middle	brain
49	chr12:11135000-11136600	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
50	chr12:11135200-11136000	Weak transcription	Psoas Muscle	Psoas

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links